placeholder image

A. Chiappori All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Phase 2 trial of nivolumab and ramucirumab for relapsed mesothelioma: HCRN-LUN15-299. 
    JTO Clin Res Rep. 2023
  • Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. 
  • Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. 

    • Contact

    full name

  • A. Chiappori

    • Quick Info

    Publications

    Collaboration